Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Levallorphan Tartrate
2. Lopac0_000771
3. Chembl1598018
4. Hms3262k04
5. Tox21_500771
6. Ccg-222075
7. Lp00771
8. Ncgc00094110-01
9. Ncgc00261456-01
10. Eu-0100771
11. L-121
12. Sr-01000076234
13. Sr-01000076234-1
Molecular Weight | 433.5 g/mol |
---|---|
Molecular Formula | C23H31NO7 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 433.21005233 g/mol |
Monoisotopic Mass | 433.21005233 g/mol |
Topological Polar Surface Area | 139 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 542 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
35
PharmaCompass offers a list of Levallorphan Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levallorphan Tartrate manufacturer or Levallorphan Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levallorphan Tartrate manufacturer or Levallorphan Tartrate supplier.
PharmaCompass also assists you with knowing the Levallorphan Tartrate API Price utilized in the formulation of products. Levallorphan Tartrate API Price is not always fixed or binding as the Levallorphan Tartrate Price is obtained through a variety of data sources. The Levallorphan Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levallorphan Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levallorphan Tartrate, including repackagers and relabelers. The FDA regulates Levallorphan Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levallorphan Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Levallorphan Tartrate supplier is an individual or a company that provides Levallorphan Tartrate active pharmaceutical ingredient (API) or Levallorphan Tartrate finished formulations upon request. The Levallorphan Tartrate suppliers may include Levallorphan Tartrate API manufacturers, exporters, distributors and traders.
Levallorphan Tartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levallorphan Tartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levallorphan Tartrate GMP manufacturer or Levallorphan Tartrate GMP API supplier for your needs.
A Levallorphan Tartrate CoA (Certificate of Analysis) is a formal document that attests to Levallorphan Tartrate's compliance with Levallorphan Tartrate specifications and serves as a tool for batch-level quality control.
Levallorphan Tartrate CoA mostly includes findings from lab analyses of a specific batch. For each Levallorphan Tartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levallorphan Tartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Levallorphan Tartrate EP), Levallorphan Tartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levallorphan Tartrate USP).